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Report of a patient with acne conglobata and
perifolliculitis capitis abscedens et suffodiens
MÓNICA LORENA CÁRDENAS, MD1, FRANCISCO LÓPEZ, MD1, LUIS HERNANDO MORENO, MD2
SUMMARY
Perifoliculitis capitis abscedens et suffodiens, dissecting folliculitis, dissecting cellulitis, or Hoffman disease is a rare,
inflammatory and chronic condition, which affects the scalp of young black men, mainly characterized by the appearance of
nodules and abscesses that drain purulent material with fistulas and pathways, leading ultimately to scarring alopecia. At
present, this condition is defined as a primary disorder of follicular keratinization, being part of the triad or tetrad of follicular
occlusion. One third of the cases are associated with acne conglobata as a primary event. Management, frustrating for many
years, is promising with the successful use of isotretinoin and a combination of medications that intervene each of its
physiopathological principles.
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RESUMEN
Perifolliculitis capitis abscedens et suffodiens, foliculitis disecante, celulitis disecante o enfermedad de Hoffman, es una
condición inflamatoria rara, crónica, que afecta el escalpo de hombres jóvenes sobre todo de raza negra, caracterizada por
aparición de nódulos y abscesos que drenan material purulento con formación de fístulas y trayectos, conduciendo finalmente
a alopecia cicatrizal. En la actualidad se entiende esta entidad como un trastorno primario de la queratinización folicular,
haciendo parte de la tríada de oclusión folicular, consistente en la presencia de 3 ó 4 de las siguientes entidades: acné
conglobata, perifoliculitis capitis abscedens et suffodiens, hidradenitis supurativa y quiste pilonidal. La tercera parte de los
casos se asocia con acné conglobata como evento primario. Su manejo, frustrante durante muchos años, tiene nuevas
esperanzas con el uso exitoso de isotretinoína y combinación de fármacos que intervienen cada uno de sus principios
fisiopatológicos.
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CASE REPORT
Twenty-two-year old male patient, residing in the
municipality of Yumbo, Colombia, who since he was
14 years of age presented the formation of suppurative
inflammatory nodular lesions on the face and back, and
since he was 20 years of age this was accompanied by
a new appearance of nodules of similar characteristics
on the scalp. Ever since then, he has received multiple
antibiotic schemes with trimetoprim-sulfametoxasol
among others, without improvement.
In September 2008, the condition worsened with the
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increase of the number of lesions and constitutional
compromise with fever and arthralgia, initially managed
at a periphery hospital center with clindamycin and
intravenous oxacillin without improvement, for which
he was sent Hospital Universitario del Valle. There
were no other personal antecedents; among the family
members, the mother had suffered from acne.
Upon admission to our institution, we found a patient,
phototype V, with multiple painful, fluctuating nodular
lesions, with abundant bad smelling spontaneous
purulent secretion, formation of fistulous tracts that
suppurated after digital pressure at a distance, compro-
mising the whole face, neck, and scalp region. All the
lesions were intercalated with uniform scarring areas
on the face and sinuous on the scalp. The hemogram
revealed leukocytosis with neutrophilia, C-reactive
protein elevated 100 times the reference value, the
rheumatoid factor, VDRL and HIV were negative. The
histopathology of samples taken from the head and
scalp reported occlusion folliculitis with mixed
inflammatory infiltrate predominantly polymorpho-
nuclear with destruction of the epidermal basal layer,
stratum corneum spongiosis, exocytosis, and formation
Figure 1. Mixed Inflammatory infiltrate with polymorphonuclear
predominance compromising the hair follicle
of intraepidermal abscesses; the inflammatory infiltrate
compromised the follicular epithelium and the adjacent
adnexal structures, findings compatible with acne
conglobata and perifolliculitis capitis abscedens et
suffodiens (Figure 1).
Upon admission, systemic treatment was begun
with 300 mg of rifampicin every 12 hours, 100 mg per
day of zinc gluconate, and 50 mg per day of oral
prednisolone with approximately 70% improvement of
the inflammatory lesions and complete improvement of
the suppuration. The patient suspended prednisolone
and received rifampicin and zinc gluconate irregularly
because of economic reasons and did not attend follow-
up control visits for five months, reappearing for
consultation in March of 2009. At that moment, the
patient had scarce inflammatory lesions, light purulent
secretion and vast scars in places previously compro-
mised (Figures 2, 3, 4).
Extension studies to discard associated seronegative
spondyloarthropathy consistent in cervical X-ray,
lumbosacral spine X-ray, in frog position and Ferguson,
did not reveal evidence of cervical abnormalities or
sacroiliitis.
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DISCUSSION
Perifolliculitis capitis abscedens et suffodiens is a
rare, chronic, progressive, and inflammatory disease of
the scalp, which almost exclusively affects Afro-
descendant males (80%) between 18 and 40 years of
age. It was detected for the first time in 1903 by Splitzer
in association with severe acne conglobata under the
name of dermatitis follicularis et perifollicularis
conglobata. In 1907, Hoffman described it as an isolated
condition.
It is currently considered a primary disorder follicular
occlusion, being part of the tetrad of follicular occlusion
along with acne conglobata, hidradenitis suppurativa
and pilonidal cysts. Bacterial infection is a secondary
event and in most cases corresponds to Staphylococcus
aureus1.
Lesions begin as follicular pustules on the occipital
region or scalp vertex then they become painful firm or
fluctuating nodules, which could be interconnected
through fistulous tracts, with discharge of purulent
material. Initially, non-scarring alopecia is developed
Figure 3. Fluctuating nodules and fistulous tracts with purulent secretion, scabs,
and vast cicatricial areas
Figure 2. Multiple nodules, cysts, and cicatricial
areas compromising the whole face
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on the nodules. The Pull test was positive. This test
consists of taking approximately 60 strands of hair and
pulling them from the proximal to the distal part, if six
or more hairs are detached this indicates the test is
positive and there is an active loss of hair. In the long
term, if the disease is not treated, hypertrophic scars,
keloids, and scarring alopecia are developed.
Coexistence with acne conglobata or hidradenitis
suppurativa is present in 1/3 of the cases, which implies
a risk for developing seronegative spondyloarthropathies
HLA-B27, with compromise of axial joints or
asymmetric peripheral arthritis. Differential diagnosis
includes other inflammatory disorders of the scalp like
tinea capitis, or a variant of folliculotropic mycosis
fungoides with follicular mucinosis, and folliculitis
decalvans, among other primary scarring alopecia.
Treatment had been unsuccessful until a few years
ago, when isotretinoin became a first-line pharma-
cological treatment with dosages of 0.5-1 mg/kg/day
alone or combined with antibiotics like trimetropin
sulfa, rifampicin, with good results, although with
recurrence. Isotretinoin is part of the group of vitamin
A polycyclic synthetic analogs that regulate
keratinization of the epidermis and hair follicles;
additionally, it is believed to inhibit the activation and
proliferation of T lymphocytes.
Historically, multiple treatments have been described
with immunosuppressant drugs like systemic
corticosteroids or intralesional, topical and systemic
antibiotic, immunomodulators like zinc sulfate and
drainage of suppurative lesions2.
Bolz et al.3, reported a clinical case with good
response and lack of recurrence with combined therapy
of 80 mg of isotretinoin plus 100 mg of dapsone daily
and then maintenance therapy with 50 mg of dapsone
interdaily.
Recently, successful treatment of this condition has
been described with tumor necrosis factor alpha (TNFá)
inhibitors like infliximab4 and adalimumab5.
Ours is a case of interest, with association of two
components of the follicular occlusion tetrad (peri-
folliculitis capitis abscedens et suffodiens and acne
conglobata), with a 70% response, in spite of the
discontinuity of the treatment with combined therapy
of zinc gluconate, prednisolone and rifampicin, where
each intervenes directly upon the relevant physiopatho-
logical factors in each of these conditions.
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Figure 3. Fistulous tracts, scabs, and a
vast area of alopecia
